What They Are Saying…
Oct 28, 2015
What The Candidates Are Saying… As the 2016 presidential race heats up,… Read More
© 2026 CSRXP- All Rights Reserved
Press & Statements
High Drug Prices: A Conversation with Iowa Voters
Oct 26, 2015
Join the Campaign for Sustainable Rx Pricing for a panel discussion on the issue of skyrocketing prescription drug prices and broader challenges ahead for Iowa and the U.S. health care system. Read More
Federation of American Hospitals Joins Campaign for Sustainable Rx Pricing
Oct 21, 2015
“Just as consumers are feeling the unsustainable cost pressure on prescription medications, so are the hospitals that purchase these essential, lifesaving prescription drugs for our patients in our care,” said Chip Kahn, President and CEO of the Federation of American Hospitals. Read More
PRESS STATEMENT: Report: Prescription Drug Spending Tops Year-Over-Year Price Growth for Major Health Categories
Oct 9, 2015
Report: Prescription Drug Spending Tops Year-Over-Year Price Growth for Major… Read More
Staggering Price Tags Continue to Threaten Patient Access
Oct 8, 2015
Exorbitant price tags associated with breakthrough treatments illustrate the broader challenges ahead for the U.S. health care system if excessive drug pricing is not addressed head on. Read More
Express Scripts sees $750 million in spending on new cholesterol drugs
Oct 7, 2015
Express Scripts has reached deals to cover two costly new cholesterol drugs and expects to spend roughly $750 million on them next year. Read More
Presidential Candidates Address Soaring Prescription Drug Costs
Sep 23, 2015
As the 2016 presidential race heats up, prominent candidates are beginning to unveil comprehensive plans to address soaring prescription drug costs and the harmful impact their price tags have on Americans. Read More
Report: Prescription Drug Spending Tops Year-over-Year Price Growth for Selected Health Categories
Sep 15, 2015
"This latest health care price growth report indicates that spending on pricey prescription medications shows no sign of slowing down. When compared to other health care services, it is clear that high cost treatments continue to top the charts as a serious threat to the sustainability of our health care system and beyond." Read More
FDA Approves New Cholesterol-Lowering Treatments
Aug 28, 2015
"The approval of Repatha is another example of a breakthrough medication with a too high price tag. With several game-changing medications in the pipeline, we need to address the underlying issue of how these prices are set from the start before they hit the market.” Read More
New KFF Poll: Unsustainable drug pricing moves ahead of ACA as GOP voters’ top health care concern
Aug 20, 2015
PRESS STATEMENT For Immediate Release August 20, 2015 Contact: John Rother… Read More
PRESS STATEMENT: National Health Expenditure Projections Show Sharp Rise in Rx Spending
Jul 29, 2015
“These numbers paint a troubling picture for the future of the American economy. The dramatic rise in prescription drug spending proves that it is more important than ever to advance a solution to monopolistic drug pricing. We cannot afford to continue on this unsustainable path.” Read More
PRESS STATEMENT: FDA Approves Praluent, New Cholesterol-Lowering Treatment
Jul 24, 2015
“Breakthrough treatments such as Praluent hold tremendous medical promise for certain patients, but it’s price tag makes us question how long the health system can sustain these costs for patients managing chronic conditions over several years.” Read More